Table 1.
Variables | Consecutive cases (16) | Second-primary lung neoplasm (10) |
---|---|---|
Gender | ||
Male | 12 (75.0%) | 9 (90%) |
Female | 4 (25.0%) | 1 (10%) |
Mean age (years) | 70 | 70.5 |
Previous surgery | 11 (68.8%) | 10 (100%) |
Lobectomy | 9 (56.3%) | 8 (80%) |
Pneumonectomy | 2 (12.5%) | 2 (20%) |
Histology | 18 | 12 |
Adenocarcinoma | 7 (38.9%) | 5 (41.7%) |
Squamous cell | 6 (33.3%) | 2 (16.7%) |
Not conclusive | 3 (16.7%) | 3 (25%) |
Not performed | 2 (11.1%) | 2 (16.7%) |
Stage | ||
Ia | 10 (62.5%) | 7 (70%) |
Ib | 3 (18.8%) | 1 (10%) |
IIa,b | 0 | 0 |
IIIa | 3 (18.8%) | 2 (20%) |
Localization | 18 | 12 |
Central | 2 (11.1%) | 1 (8.3%) |
Peripheral | 16 (88.9%) | 11 (91.7%) |
Multiple ipsilateral neoplasm | 2 (12.5%) | 2 (10%) |
Malignancy presentation | ||
Metachronous | 5 (31.3%) | 5 (50%) |
Synchronous | 2 (12.5%) | 2 (20%) |
Synchronous or metastasis of primary lung cancer | 3 (18.8%) | 3 (30%) |
Primary | 5 (31.3%) | 0 |
Metastasis of primary lung cancer | 1 (6.3%) | 0 |
Oncological comorbidities | 4 (25%) | 2 (20%) |
Previous radiation therapy and chemotherapy for primary lung neoplasm | 3 (18.8%) | 2 (20%) |